findmyKOL

Rishi Singh, MD

Enriched profile

Chair, Department of Ophthalmology, Harvard Medical School and Mass General Brigham · Mass General Brigham

ORCIDNPI
Region🇺🇸 Boston, MA · Northeast · United StatesSpecialtyOphthalmologyFocusRetinal Diseases and Treatments+4
Active KOLfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2026Online presenceverified 2026Payments2021–2025NIH fundingNone on fileWhy? →

Rishi Singh is Chair, Department of Ophthalmology, Harvard Medical School and Mass General Brigham at Mass General Brigham. OpenAlex indexes 589 publications with 13,344 citations (h-index 48); ClinicalTrials.gov lists 3 registered studies with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 5% of Ophthalmology profiles in the findmyKOL directory.

Data verified 14 Aug 2026

Overview

Updated 27 Aug 2026

Rishi P. Singh, MD, is Chair, Department of Ophthalmology, Harvard Medical School and Mass General Brigham. The public record shows 589 publications with 13,344 citations (h-index 48), centered on Retinal Diseases and Treatments, Retinal Imaging and Analysis, Retinal and Optic Conditions. It also documents an investigator role on 3 registered clinical trials, industry payments reported by 44 companies.

  • Most recent indexed publication: 2026 · Eye (London, England)
  • Top research focus: Retinal Diseases and Treatments
  • 3 registered trials on ClinicalTrials.gov
  • Open Payments reporting from 44 companies

Generated from the cited public record · current as of 27 Aug 2026. Every fact links its source below.

Indications focus

from trials led + research topics
Diabetic Complications2 trialsDiabetic Retinopathy / DME2 trialsDiabetic Retinopathy2 trialsMacular Degeneration (AMD)1 trialEdema1 trialMacular Edema1 trial

Research focus

OpenAlex concept fingerprint
Retinal Diseases and TreatmentsRetinal Imaging and AnalysisRetinal and Optic ConditionsRetinal and Macular SurgeryOcular Diseases and Behçet’s Syndrome

Drugs & molecules

across trials, industry payments and publications
Syfovregeneric · PegcetacoplanClinical trialsIndustry payments104Publications3Eyleageneric · AfliberceptClinical trialsIndustry payments87Publications2Vabysmogeneric · FaricimabClinical trialsIndustry payments60Publications2

Works with

trial sponsors and companies reporting payments
Apellis Pharmaceuticals, Inc.Clinical trialsIndustry payments166Regeneron Healthcare Solutions, Inc.Clinical trialsIndustry payments98Genentech USA, Inc.Clinical trialsIndustry payments67

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
589publications

Distinct works indexed by OpenAlex, matched via ORCID; 35 in PubMed.

13,344citations

Total citations across indexed works.

48h-index

Hirsch index (OpenAlex). i10-index 180.

Clinical & industry

trials, payments and federal funding
3clinical trials

Investigator role on registered studies.

View trials
44companies · 2021–2025

Companies reporting payments to CMS. Facts, not judgments.

View payments
0NIH grants

Federally funded research awards.

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

Telephone

Practice address and telephone from the federal NPPES registry.

Sign in to view contact details →

Clinical trials

Updated 27 Aug 2026

Listed as an investigator on 3 registered studies on ClinicalTrials.gov. The most recent:

Industry payments

Updated 27 Aug 2026

44 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:

Medicare prescribing footprint (2023)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Sensory organs

    100%
    Carbonic Anhydrase Inhibitor100%
    Dorzolamide-Timolol100%
    Part D<11 patients
Where care is delivered (Part B)100% facility · 0% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

We didn't find any NIH-funded research awards for this person in NIH RePORTER. Why? →

Congress activity

Updated 27 Aug 2026

3 congress contributions (2016–2023) across ADA, ASTRO per OpenAlex. The most recent:

Published abstracts are attributed via the same ORCID-disambiguated authorship as publications, so each is DOI-verified. Podium roles (invited talks, session chairs) and oral/poster type are added as program data is confirmed.

Publications

Updated 27 Aug 2026

Their five most recent publications, matched to their ORCID record and linked to PubMed.

Network

Updated 27 Aug 2026

The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.

Peter K. Kaiser104Justis P. Ehlers91Katherine E. Talcott91

Online presence

Updated 27 Aug 2026

This person's own public accounts first, then places where others mention them. Two different things, listed separately.

Owned accounts

public accounts run by this person
  • Doximity

    doximity.com/pub/rishi-singh-md

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com
  • Facebook

    facebook.com/docrishisingh

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →facebook.com
  • Instagram

    instagram.com/drrishisingh

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →instagram.com
2 more verified accounts behind the reveal.Reveal →

Mentions by others

where others cite or feature them
  • Other

    eye.hms.harvard.edu/people/rishi-singh-md

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →eye.hms.harvard.edu
  • Other

    giving.massgeneral.org/stories/rishi-singh-md-named-mgb-chair-of-ophthalmology

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →giving.massgeneral.org
  • YouTube

    youtube.com/watch

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →youtube.com
1 more mention behind the reveal.Reveal →

We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.

Background & recognition

Updated 27 Aug 2026

Credentials, appointments and honors, newest first, each linked to the public source it came from.

Education

degrees and training on record
  • MD

    Boston University School of Medicine

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doctors.masseyeandear.org
  • BS (medical sciences)

    Boston University

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doctors.masseyeandear.org
  • Residency

    Ophthalmology, Massachusetts Eye and Ear / Harvard Medical School

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doctors.masseyeandear.org
  • Fellowship

    Medical and Surgical Vitreoretinal Disease, Cole Eye Institute, Cleveland Clinic

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doctors.masseyeandear.org
  • Board Certified

    Ophthalmology

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →doctors.masseyeandear.org

Editorial & leadership roles

journal and society appointments
1 more role behind the reveal.Reveal →

Awards & honors

honors on the public record

Secondary affiliations

appointments beyond the home institution

Media & interviews

press, podcasts and appearances
1 more media item behind the reveal.Reveal →

Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.

Similar KOLs

Other experts from the same institution or the same specialty.